Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis

INTRODUCTION: Biologic therapies have improved the clinical management of ankylosing spondylitis (AS). Few head-to-head studies have directly compared the efficacy of these agents. This study was conducted to indirectly compare the efficacy of biologic agents for treatment of active AS. METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Betts, Keith A., Griffith, Jenny, Song, Yan, Mittal, Manish, Joshi, Avani, Wu, Eric Q., Ganguli, Arijit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127962/
https://www.ncbi.nlm.nih.gov/pubmed/27747581
http://dx.doi.org/10.1007/s40744-016-0038-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127962/
https://www.ncbi.nlm.nih.gov/pubmed/27747581
http://dx.doi.org/10.1007/s40744-016-0038-y

Ejemplares similares